Lee's experience in biopharma and leadership in manufacturin...
Lee's experience in biopharma and leadership in manufacturing and operations could provide a valuable perspective to Vaxcyte's board. His expertise in global vaccine supply may benefit the progress of VAX-24 and VAX-31.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000001775adcbbdcdeb.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment